Christopher Dinsmore - 16 May 2024 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Chief Scientific Officer
Signature
/s/ Christopher Murphy, Attorney-in-Fact
Issuer symbol
THRD
Transactions as of
16 May 2024
Net transactions value
$0
Form type
4
Filing time
20 May 2024, 16:35:33 UTC
Previous filing
05 Jan 2024
Next filing
17 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Employee Stock Option (right to buy) Award $0 +210,000 $0.000000 210,000 16 May 2024 Common Stock 210,000 $14.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total shares vest on May 16, 2025, and thereafter 2.08333% of the total shares underlying the award shall vest in equal monthly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.